• 1. Department of Urology, Xi'an Aerospace General Hospital, Xi'an 710100, China;
  • 2. Xi'an Beilin District Center for Disease Control and Prevention, Xi'an 710100, China;
  • 3. Department of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China;
  • 4. Department of Urology, Shanxi Province Hospital, Xi'an 710100, China;
FUChong-de, Email: fchd1984@163.com
Export PDF Favorites Scan Get Citation

Objective To assess the methodological and reporting quality of systematic reviews/Meta-analyses (SRs/MAs) of transurethral procedure for benign prostatic hyperplasia (BPH). Method We electronically searched databases including PubMed, The Cochrane Library (Issue 12, 2014), Sciverse, CNKI, VIP and WanFang Data from inception to December 2014 to collect SRs/MAs of transurethral procedure about BPH. Two reviewers independently screened literature and assessed the methodological and reporting quality of included SRs/MAs by AMSTAR and PRISMA checklists. Results A total of 33 SRs/MAs were included. The results of qualitative analysis showed that:the main methodological weakness of included SRs/MAs included the lack of protocol, disappropriate conclusion formulation, the lack of publication bias assessment, and the lack of stating the conflict of interest. The average score of AMSTAR scale was 6.27±2.14. There were 11 items in PRISMA checklist with coincidence rate over 80%, 8 items between 50% to 80%, and 8 items less than 50%. Conclusion The methodological and reporting quality of SR/MA of transurethral procedure for BHP is low, and that may decrease the reliability and value of results from SRs/MAs in the field. Future SRs/MAs should strictly follow the related reporting guidelines in order to improve the methodological and reporting quality, so as to provide more reliable evidence for clinical decision.

Citation: LITao, WEINa-sha, FUChong-de, FUSheng-jun, YANGLi, WANGZhi-ping, CHENGuang-yu, CHENGJi. Methodological and Reporting Quality of Systematic Reviews/Meta-analyses of Transurethral Procedure for Benign Prostatic Hyperplasia. Chinese Journal of Evidence-Based Medicine, 2015, 15(10): 1224-1230. doi: 10.7507/1672-2531.20150202 Copy

  • Previous Article

    Clinical Features of Chronic Fatigue Syndrome Cases with Pathogens Infection: A Systematic Review
  • Next Article

    Evaluation of Reliability and Validity of Quality of Working Life Scale (QWL7-32)